
The latest news and exclusive analysis across the FDA-regulated industries from former FDA professionals and industry experts. Save time gathering the critical industry intelligence you need to act on.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 429 | Founded | 5 years ago | Last Issue | 6 days ago |
| Active | |||||

We recently shared some observations on how a new eQMS can be underbuilt for the stage a company is entering. Today, we have an actual case study that shows what that risk looks like in a real operation.
A clinical-stage biotech approached...
Subscribe to our podcast, The Life Science Rundown, if you haven’t already.
With so many new subscribers now coming to the newsletter each week, we’re resharing one of our favorite conversations from a few years back.
We’re bringing it b...
Watch now (74 mins) | CDER tells you how to put new approach methodologies in front of reviewers, FDA finalizes guidance on patient preference information across the product life cycle, plus a warning letter breakdown.
Welcome to Insider i...
There's been a lot happening. Here's a simple guide for catching up with recent personnel changes.
It’s been hard to keep up with all the personnel changes at the FDA recently. In the last few weeks alone, the agency has lost its commissio...
A few of the configuration gaps we see that cause compliance problems later, and where to close them.
We’ve been seeing a specific situation pretty regularly: a growing clinical-stage firm discovers that the eQMS it bought maybe two years...
Subscribers, engagement, traffic and sponsorship for The FDA Group's Insider Newsletter.
| Subscribers | Engagement | 78 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #89 |
The writers behind this newsletter.
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates.
You can find recent issues that have been published by The FDA Group's Insider Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The FDA Group's Insider Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The FDA Group's Insider Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The FDA Group's Insider Newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The FDA Group's Insider Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.